(Q47858677)

6 February 2018

title

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF. (English)

1 reference

6 February 2018

1 reference

1 reference

J Andrew Bristol

1

1 reference

6 February 2018

Mingzhu Zhu

2

1 reference

6 February 2018

Hong Ji

3

1 reference

6 February 2018

Mervat Mina

4

1 reference

6 February 2018

Yuefeng Xie

5

1 reference

6 February 2018

Lori Clarke

6

1 reference

6 February 2018

Suzanne Forry-Schaudies

7

1 reference

6 February 2018

David L Ennist

8

1 reference

6 February 2018

publication date

1 June 2003

1 reference

6 February 2018

published in

Molecular Therapy

1 reference

6 February 2018

volume

7

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

755-764

1 reference

6 February 2018

Replicative adenoviruses for cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Cell cycle-regulated transcription in mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

The regulation of E2F by pRB-family proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

An adenovirus type 5 early gene function regulates expression of other early viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Region E3 of adenovirus: A cassette of genes involved in host immunosurveillance and virus-cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

ONYX-015: clinical data are encouraging

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

DNA replication of first-generation adenovirus vectors in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900103-5

7 January 2021

10.1016/S1525-0016(03)00103-5

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018